Close X
Sunday, December 22, 2024
ADVT 
International

Premature to declare global pandemic over: experts

Darpan News Desk The Canadian Press, 16 Sep, 2022 10:13 AM
  • Premature to declare global pandemic over: experts

TORONTO - While the head of the World Health Organization says the end of the COVID-19 pandemic is "in sight," some Canadian experts warn it would be premature to declare the global health crisis over.

Their comments come after WHO Director-General Tedros Adhanom Ghebreyesus announced Wednesday that the number of deaths attributed to COVID-19 worldwide in the last week reached the lowest point since the pandemic's onset.

He also urged governments to stay vigilant so we don't backslide at a pivotal moment.

Dr. Fahad Razak, who headed up the recently disbanded group of scientists advising Ontario's government on COVID-19, says coronavirus variants have traditionally cropped up during the fall and winter, leading to a surge in cases and deaths.

He says it stands to reason that could happen again this year.

Razak says if we don't see a new wave during the peak COVID season, then experts may be more willing to declare the end of the pandemic in the spring.

But Colin Furness, an assistant professor at the University of Toronto's Dalla Lana school of public health, says the pandemic is still wreaking havoc, leading to excess death and a labour shortage that's further stunting the already strained health-care system.

This report by The Canadian Press was first published Sept. 16, 2022.

MORE International ARTICLES

One person killed in shooting in Oakland

One person killed in shooting in Oakland
Police found the victim off the side of a road with apparent gunshot wounds. The man died from his injuries at the scene and his identity is being withheld until his next of kin is notified, the police said.

One person killed in shooting in Oakland

WHO calls on Pfizer to make its COVID pill more available

WHO calls on Pfizer to make its COVID pill more available
WHO Director-General Tedros Adhanom Ghebreyesus said during a news briefing that Pfizer's treatment was still too expensive. He noted that most countries in Latin America had no access to Pfizer’s drug, Paxlovid , which has been shown to cut the risk of COVID-19 hospitalization or death by up to 90%.    

WHO calls on Pfizer to make its COVID pill more available

Rare cases of COVID returning pose questions for Pfizer pill

Rare cases of COVID returning pose questions for Pfizer pill
Paxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disease. The U.S. government has spent more than $10 billion to purchase enough pills to treat 20 million people.    

Rare cases of COVID returning pose questions for Pfizer pill

CDC probing 109 liver illnesses in kids, including 5 deaths

CDC probing 109 liver illnesses in kids, including 5 deaths
About two dozen states reported suspected cases after the Centers for Disease Control and Prevention put out a call for doctors to be on the lookout for surprising cases of hepatitis. The cases date back to late October in children under 10. So far, only nine cases in Alabama have been confirmed.    

CDC probing 109 liver illnesses in kids, including 5 deaths

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

FDA restricts J&J's COVID-19 vaccine due to blood clot risk
FDA officials said in a statement that they decided to restrict J&J's vaccine after taking another look at data on the risk of life-threatening blood clots within two week of vaccination.

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report
Preliminary research suggests it is about 25 per cent more transmissible than the BA.2 subvariant that is currently dominant nationally, according to the Centers for Disease Control and Prevention.

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report